ArticleJMA journal2026
Crisis Management of Emerging/Re-Emerging Infectious Diseases in People with HIV in Japan.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging and re-emerging infectious diseases have disproportionately affected marginalized groups such as people with HIV (PWH), yet their specific needs are often overlooked. Drawing on the experience of IMSUT Hospital in Minato ward, central Tokyo-a district that includes Roppongi and Ginza, and serves as a referral center for HIV care-during the COVID-19 pandemic, we highlight how structural factors, stigma, and delayed access to care shaped the impact on PWH. While general medical responses evolved rapidly, HIV-specific vulnerabilities such as vaccine non-responsiveness and prolonged infection persisted. The subsequent mpox outbreak in Tokyo, affecting many PWH, further illustrated how emerging infections in marginalized communities can present with population-specific complications influenced by social and epidemiological contexts. Without such measures, outbreaks among PWH and other vulnerable groups may remain undetected for longer periods and spread more widely, thereby deepening existing disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.